Digital Therapeutics (DTx) Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The global digital therapeutics (DTx) market is anticipated to grow at a considerable CAGR of 29.0% during the forecast period (2021-2027). The growing pervasiveness of chronic diseases is one of the prime factors affecting and driving the market. According to the World health organization (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Chronic diseases are having high levels of uncertainty and a new care lifestyle would support their behaviour. Through digital health technology, it will enhance prevention, diagnosis along with proper management of cardiovascular diseases that leads to getting better health outcomes.

To Request a Sample of our Report on Digital Therapeutics (DTx) Market: https://www.omrglobal.com/request-sample/digital-therapeutics-market

The key players operating in the global digital therapeutics (DTx) market had been adopting strategies such as new launches to gain major market share. For instance, in July 2021, one of the software-enabled healthcare platform companies across the globe named Happify Health had introduced Ensemble, which is considered as first transdiagnostic prescription digital therapeutic in order to do the treatment of patients suffering from Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD).

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered-

· By Product Type

· By Sales Channel

· By Application

• Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

· Competitive Landscape- Otsuka Pharmaceutical Co., Ltd., Livongo Health, Omada Health, Inc., WellDoc, and Pear Therapeutics, Inc.

(Get 15% Discount on Buying this Report)

A full Report of Digital Therapeutics (DTx) Market is Available at: https://www.omrglobal.com/industry-reports/digital-therapeutics-market

Global Digital Therapeutics (DTx) Market

By Product Type

• Software

• Device

By Sales Channel

• B2C

• B2B

By Application

• Preventive Applications

• Treatment/Care-related Applications

Global Digital Therapeutics (DTx) Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Company Profiles

· Alex Therapeutics AB

· 2Morrow Inc.

· Akili Interactive Labs. Inc.

· Ayogo Health

· Canary Health

· Click Therapeutics, Inc.

· CogniFit

· Ginger

· HAPPIFY HEALTH

· Kaia Health

· Livongo Health

· Noom, Inc.

· Mindstrong HealthGmbH

· Omada Health, Inc.

· Otsuka Pharmaceutical Co., Ltd.

· Pear Therapeutics, Inc.

· ResMed

· TrialCard

· Wellthy Therapeutics Pvt Ltd.

· WellDoc

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.